Page last updated: 2024-08-18

pyrroles and Experimental Mammary Neoplasms

pyrroles has been researched along with Experimental Mammary Neoplasms in 30 studies

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (6.67)	18.7374
1990's	2 (6.67)	18.2507
2000's	9 (30.00)	29.6817
2010's	14 (46.67)	24.3611
2020's	3 (10.00)	2.80

Authors

Authors	Studies
Chen, Q; Jiang, C; Li, T; Liu, J; Lu, L; Shan, X; Sun, G; Wei, S; Yin, X; Zhang, X	1
Danciu, O; Emmadi, R; Hoskins, K; Kumar, S; Nair, RS; Rana, A; Rana, B; Sethupathi, P; Singh, SK; Sinha, SC; Sondarva, G; Thatcher, GRJ; Viswakarma, N	1
Ding, J; Hu, LD; Kong, X; Liao, HP; Ma, QY; Meng, LH; Sun, P; Wang, HL; Wang, RJ; Wang, Y; Xu, L; Zhang, X	1
Huang, J; Li, N; Meng, Z; Zhang, C	1
Chen, H; Li, P; Ran, H; Wan, J; Wang, Z; Yang, Q; Zhang, L	1
Dong, B; Jha, BK; Nguyen, CT; Polyakova, I; Silverman, RH	1
Askeland, RW; Cyr, AR; Gillum, MP; Spanheimer, PM; Weigel, RJ; Woodfield, GW	1
He, S; Wang, Y; Yin, T	1
He, S; Shen, G; Wang, Y; Yin, T	1
Chen, XW; Diehn, M; Sun, JG; Wang, J; Zhang, LP	1
Fontaine, SD; Hann, B; Mattis, AN; Renslo, AR; Sambucetti, L; Shi, Y; Spangler, B; Wells, JA	1
Boring, D; Grubbs, CJ; Juliana, MM; Lubet, RA; Ruppert, JM; Steele, VE	1
Murugesan, S; Nadkarni, DH; Rayburn, ER; Velu, SE; Wang, W; Zhang, R	1
Byrne, AT; Callanan, JJ; Curran, KM; Gallagher, WM; Hall, M; Lecomte, R; McGee, S; Mongrain, K; Murtagh, J; O'Connor, AE; O'Neill, K; O'Shea, DF; Rousseau, JA	1
Gu, JW; Huang, M; Miele, L; Tucker, KB; Wells, J; Young, E	1
Figlin, RA; Pal, SK; Yu, H	1
Morimoto, J; Otsuki, Y; Shibata, MA; Tanaka, Y	1
Katanasaka, Y; Kitamura, Y; Kodera, Y; Koizumi, F; Nishio, K; Tamura, T; Tsuda, H	1
Akhurst, RJ; Babb, JS; Barcellos-Hoff, MH; Bouquet, F; Demaria, S; DeWyngaert, JK; Formenti, SC; Hann, B; Lonning, SM; Pal, A; Pilones, KA	1
Baaj, Y; Cook-Moreau, J; Faucher-Durand, K; Fourcade, L; Funalot, B; Mollard, S; Mousseau, Y; Nizou, A; Plainard, X; Qiu, H; Richard, L; Sturtz, FG	1
Gorelik, E; Huang, X; Laird, AD; Watkins, S; Wolf, SF; Wong, MK; Yi, H	1
Ballinari, D; Bravo, R; Cappella, P; Carpinelli, P; Ceruti, R; Croci, V; Fancelli, D; Gianellini, L; Giorgini, ML; Moll, J; Pesenti, E; Rusconi, L; Sola, F; Soncini, C; Storici, P; Varasi, M; Vianello, P; Zugnoni, P	1
Boschi, F; D'Onofrio, M; Faccioli, N; Marzola, P; Pozzi Mucelli, R; Sbarbati, A	1
Kamaike, K; Kashiwagi, K; Kawashima, E; Nakanishi, Y; Ohba, Y; Terui, Y; Tomitori, H	1
Groot, K; Halmos, G; Nagy, A; Schally, AV; Szepeshazi, K	1
Nagy, A; Schally, AV; Szepeshazi, K	1
Brandt, R; Hynes, NE; Wong, AM	1
Cherrington, JM; Griffin, RJ; Park, H; Song, CW; Wild, R; Williams, BW	1
Rockwell, S	1
Carvajal, EJ; Carvajal, G; Medina, VZ; Yáñez, R	1

Other Studies

30 other study(ies) available for pyrroles and Experimental Mammary Neoplasms

Article	Year
Polypyrrole-based double rare earth hybrid nanoparticles for multimodal imaging and photothermal therapy. Journal of materials chemistry. B, 2020, 01-22, Volume: 8, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; Injections, Intravenous; Mammary Neoplasms, Experimental; Materials Testing; Metals, Rare Earth; Mice; Mice, Inbred ICR; Multimodal Imaging; Nanoparticles; Photothermal Therapy; Polymers; Pyrroles	2020
Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 2020, 04-07, Volume: 117, Issue:14 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cyclophilin A; Female; Humans; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Experimental; MAP Kinase Kinase Kinases; Mice; Mitogen-Activated Protein Kinase Kinase Kinase 11; NFATC Transcription Factors; Phosphorylation; Primary Cell Culture; Protein Kinase Inhibitors; Pyridines; Pyrroles; T-Lymphocytes, Cytotoxic; Tumor Escape	2020
PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8 Journal for immunotherapy of cancer, 2021, Volume: 9, Issue:8 Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Fatty Acids; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Pyrroles; Random Allocation; Tumor Microenvironment	2021
Metal-Organic Framework as a Microreactor for in Situ Fabrication of Multifunctional Nanocomposites for Photothermal-Chemotherapy of Tumors in Vivo. ACS applied materials & interfaces, 2018, Nov-14, Volume: 10, Issue:45 Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Carriers; Female; Ferric Compounds; Hyperthermia, Induced; Mammary Neoplasms, Experimental; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Nanocomposites; Phototherapy; Polymers; Pyrroles; Random Allocation	2018
Polypyrrole-coated phase-change liquid perfluorocarbon nanoparticles for the visualized photothermal-chemotherapy of breast cancer. Acta biomaterialia, 2019, Volume: 90 Topics: Animals; Coated Materials, Biocompatible; Docetaxel; Female; Fluorocarbons; HeLa Cells; Humans; Hyperthermia, Induced; Infrared Rays; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Phototherapy; Polymers; Pyrroles	2019
Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy. Molecular therapy : the journal of the American Society of Gene Therapy, 2013, Volume: 21, Issue:9 Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Combined Modality Therapy; eIF-2 Kinase; Endoribonucleases; Female; Immunity, Innate; Indoles; Kidney Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Oncolytic Virotherapy; Oncolytic Viruses; Prostatic Neoplasms; Pyrroles; Sunitinib; Vesiculovirus	2013
Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy. Annals of surgery, 2014, Volume: 259, Issue:4 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Estrogen Receptor alpha; Female; Flow Cytometry; Humans; Indoles; Mammary Neoplasms, Experimental; MAP Kinase Signaling System; MCF-7 Cells; Mice; Piperidines; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Pyrroles; Quinazolines; Random Allocation; Signal Transduction; Sunitinib; Tamoxifen; Transcription Factor AP-2	2014
Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model. Molecular medicine reports, 2015, Volume: 12, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression; HMGB1 Protein; Imidazoles; Indoles; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice, Inbred BALB C; Neoplasm Transplantation; Pyrroles; Sunitinib; Toll-Like Receptor 7; Toll-Like Receptor 8; Up-Regulation	2015
HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer Model. Oncology research, 2014, Volume: 22, Issue:3 Topics: Acriflavine; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Female; Hypoxia-Inducible Factor 1; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Myeloid Cells; Necrosis; Neovascularization, Pathologic; Protein Multimerization; Pyrroles; Spleen; Sunitinib; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2014
Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling. Oncotarget, 2016, Mar-01, Volume: 7, Issue:9 Topics: Adaptor Proteins, Signal Transducing; Animals; Breast Neoplasms; Cell Cycle Proteins; Estrogen Receptor alpha; Female; Humans; Isoquinolines; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Knockout; Neoplastic Stem Cells; Phosphoproteins; Phosphorylation; Pyridines; Pyrroles; Smad3 Protein; Transcription Factors; Transforming Growth Factor beta; Wnt1 Protein; YAP-Signaling Proteins	2016
A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models. Journal of medicinal chemistry, 2016, 12-22, Volume: 59, Issue:24 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Duocarmycins; Female; Ferrous Compounds; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Molecular Structure; Prodrugs; Pyrroles; Structure-Activity Relationship; Tumor Cells, Cultured	2016
Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis. Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:2 Topics: Alkylating Agents; Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Atorvastatin; Bexarotene; Cell Proliferation; Diet; Disease Models, Animal; Female; Genes, erbB-2; Heptanoic Acids; Lovastatin; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mice, Knockout; Mice, Transgenic; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Retinoid X Receptors; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Tumor Suppressor Protein p53	2009
In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Molecular Structure; Pyrroles; Quinolones; Structure-Activity Relationship; Xenograft Model Antitumor Assays	2009
Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment. British journal of cancer, 2009, Nov-03, Volume: 101, Issue:9 Topics: Animals; Cell Line, Tumor; Cells, Cultured; Endothelial Cells; Female; Humans; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Photochemotherapy; Photosensitizing Agents; Positron-Emission Tomography; Pyrroles; Tissue Distribution	2009
SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells. Cancer biology & therapy, 2010, Oct-01, Volume: 10, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Profiling; Humans; Immunohistochemistry; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Protein Kinase Inhibitors; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Sunitinib; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2	2010
Deciphering the anticancer mechanisms of sunitinib. Cancer biology & therapy, 2010, Oct-01, Volume: 10, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Profiling; Indoles; Mammary Neoplasms, Experimental; Mice; Models, Biological; Neovascularization, Pathologic; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Tumor Burden; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2	2010
Sunitinib suppresses tumor growth and metastases in a highly metastatic mouse mammary cancer model. Anticancer research, 2011, Volume: 31, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Blotting, Western; Body Weight; Female; Humans; Immunoenzyme Techniques; Indoles; Lymphatic Metastasis; Lymphatic Vessels; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Pyrroles; Sunitinib; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2011
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3. Breast cancer research : BCR, 2011, Jun-21, Volume: 13, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Endothelial Cells; Female; Humans; Indoles; Lymphangiogenesis; Lymphatic Metastasis; Lymphatic Vessels; Mammary Neoplasms, Experimental; Mice; Neovascularization, Pathologic; Phosphorylation; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor D; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3	2011
TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Nov-01, Volume: 17, Issue:21 Topics: Amino Acids; Animals; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Protein Serine-Threonine Kinases; Pyrazoles; Pyrroles; Radiation-Sensitizing Agents; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Transforming Growth Factor beta1; Xanthenes; Xenograft Model Antitumor Assays	2011
Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model. Breast cancer research and treatment, 2012, Volume: 134, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carcinoma 256, Walker; Cell Movement; Cells, Cultured; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fingolimod Hydrochloride; Indoles; Male; Mammary Neoplasms, Experimental; Myocytes, Smooth Muscle; Neoplasm Transplantation; Propylene Glycols; Proto-Oncogene Proteins c-sis; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Statistics, Nonparametric; Sunitinib; Tumor Burden; Tyrphostins	2012
Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein. Cancer research, 2002, Oct-15, Volume: 62, Issue:20 Topics: Angiogenesis Inhibitors; Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; B7-2 Antigen; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Female; Immunoglobulin G; Indoles; Interferon-gamma; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Oxindoles; Propionates; Protein-Tyrosine Kinases; Pyrroles; Recombinant Fusion Proteins; Spleen	2002
PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jul-01, Volume: 12, Issue:13 Topics: Animals; Antineoplastic Agents; Aurora Kinase B; Aurora Kinases; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HeLa Cells; HL-60 Cells; Humans; Inhibitory Concentration 50; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Molecular Structure; Phenotype; Phosphorylation; Protein Serine-Threonine Kinases; Pyrazoles; Pyrroles; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction	2006
Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging. La Radiologia medica, 2007, Volume: 112, Issue:3 Topics: Adenocarcinoma; Albumins; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Colonic Neoplasms; Contrast Media; Gadolinium DTPA; Indoles; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Microcirculation; Neoplasms, Experimental; Organometallic Compounds; Oxindoles; Propionates; Protein-Tyrosine Kinases; Pyrroles; Rats; Tamoxifen	2007
Synthesis and evaluation of 2-pyrrolepolyamide-2'-deoxyguanosine 5'-phosphate. Nucleic acids symposium series (2004), 2007, Issue:51 Topics: Animals; Antineoplastic Agents; Carcinoma; Guanosine Monophosphate; Mammary Neoplasms, Experimental; Mice; Pyrroles	2007
Targeted cytotoxic luteinizing hormone releasing hormone (LH-RH) anlalogs inhibit growth of estrogen independent MXT mouse mammary cancers in vivo by decreasing cell proliferation and inducing apoptosis. Anti-cancer drugs, 1997, Volume: 8, Issue:10 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Division; Cell Survival; DNA, Neoplasm; Doxorubicin; Estrogens; Female; Gonadotropin-Releasing Hormone; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Hormone-Dependent; Pyrroles; Receptors, LHRH	1997
Effective treatment of advanced estrogen-independent MXT mouse mammary cancers with targeted cytotoxic LH-RH analogs. Breast cancer research and treatment, 1999, Volume: 56, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Division; Doxorubicin; Drug Delivery Systems; Estrogens; Female; Gonadotropin-Releasing Hormone; Growth Inhibitors; Injections, Intravenous; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Hormone-Dependent; Pyrroles	1999
Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents. Oncogene, 2001, Sep-06, Volume: 20, Issue:39 Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Genes, erbB-2; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Paclitaxel; Pyrimidines; Pyrroles; Receptor, ErbB-2	2001
Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer research, 2002, Mar-15, Volume: 62, Issue:6 Topics: Animals; Cell Division; Chemotherapy, Adjuvant; Female; Fibrosarcoma; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Nude; Oxindoles; Pancreatic Neoplasms; Propionates; Pyrroles; Radiation-Sensitizing Agents; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor	2002
Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro. The British journal of cancer. Supplement, 1978, Volume: 3 Topics: Animals; Cell Survival; In Vitro Techniques; Lethal Dose 50; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oxygen; Pyrroles; Radiation-Sensitizing Agents; Thiazoles	1978
Lactic dehydrogenase activity and aerobic glycolysis in tumors. National Cancer Institute monograph, 1967, Volume: 27 Topics: Amides; Animals; Benz(a)Anthracenes; Dialysis; Female; Glycerolphosphate Dehydrogenase; Glycolysis; Hydroxybutyrate Dehydrogenase; Isoenzymes; Kinetics; L-Lactate Dehydrogenase; Mammary Neoplasms, Experimental; Oxalates; Pyrroles; Rats; Sarcoma 180	1967